Prostate Cancer

How to read biparametric MRI in men with a clinical suspicious of prostate cancer: Pictorial review for beginners with public access to imaging, clinical and histopathological database.

Prostate Magnetic Resonance Imaging (MRI) is increasingly being used in men with a clinical suspicion of prostate cancer (PCa). Performing prostate MRI without the use of an intravenous contrast (IV) agent in men with a clinical suspicion of PCa can lead to reduced MRI scan time.

Prostate Cancer Awareness in the Time of COVID

As the world continues to be affected by the COVID-19 pandemic, severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), prostate cancer awareness may seem like something that could be forgotten this year. Just today in the state where I live, Illinois, we learned of 1,880 new cases of coronavirus yesterday, with over 180,000 deaths in the United States (US) since the pandemic started. Our normal lives have been disrupted, with restaurants and gyms open only with significant restrictions, and church services limited in number or only held online.

Making Quality Inferences from GU ASCO Quality of Life Data: How I Interpret the Evidence

As medical oncologists, urologists, radiation oncologists, and other clinicians, we find ourselves feeling very comfortable understanding Kaplan Meier survival curves and forest plots describing subgroups in the setting of different treatments. We review CTCAE adverse event data, drilling down on the 10% of adverse effects that happen most commonly, and nearly always arrive at the conclusion that “such and such treatment is relatively well tolerated”.

CDC Issues Key Clarification on Guideline for Prescribing Opioids for Chronic Pain

San Francisco, CA (UroToday.com) -- Agency Clarifies CDC Guideline Not Meant to Limit Access to Appropriate Pain Management for Individuals with Cancer, Sickle Cell Disease. The American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), and the National Comprehensive Cancer Network® (NCCN®) are pleased to acknowledge receipt of a key clarification from the Centers for Disease Control and Prevention (CDC) on prescribing opioids to manage pain from certain conditions. The clarification regarding CDC's Guideline for Prescribing Opioids for Chronic Pain----issued in a letter from the agency to ASCO, ASH, and NCCN----comes as a result of a collaborative effort by these organizations to clarify CDC's opioid prescribing guideline in order to ensure safe and appropriate access for cancer patients, cancer survivors, and individuals with sickle cell disease.

A Million Faces: What Prostate Cancer Awareness Means to Me

Prostate cancer is something that touches most of us, at least indirectly, at some point in our lives. It is the most common cancer in American men, and the second leading cause of cancer death in this country. Our continued efforts as clinicians, researchers, patients, family members, loved ones, and advocates are critical if this

Page 2 of 4

Prostate Cancer

Login